EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • California
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of July 18, 2019, by and between MDxHealth, Inc., a company incorporated in the state of Delaware and with an office located at 15279 Alton Pkwy, Suite 100, Irvine, CA 92618 (“Company”), and Mr. Ron Kalfus (“Executive”).
AGREEMENT FOR THE PROVISION OF A LOAN FACILITY OF UP TO €9,000,000 Dated 23 September 2019 BetweenLoan Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • England
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionKREOS CAPITAL VI (UK) LIMITED, a company incorporated in England and Wales under registration number 11535385 whose registered office is at Amf Building, 25 Old Burlington Street, London W1S 3AN (the “Lender”, which expression shall include its successors and assigns);
LEASE BETWEEN ALTON CORPORATE PLAZA LLC AND MDXHEALTH, INC. LEASELease • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • California
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionTHIS LEASE is made as of December 17, 2019 , by and between ALTON CORPORATE PLAZA LLC, a Delaware limited liability company, hereafter called “Landlord,” and MDXHEALTH, INC., a Delaware corporation, hereafter called “Tenant.”
AMENDMENT NO. 1 TO RESTATED AND AMENDED LICENSE AGREEMENTLicense Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • Maryland
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionThis AMENDMENT NO.1 TO THE RESTATED AND AMENDED LICENSE AGREEMENT (this “Amendment”) is entered into as of April 15th, 2005, by and between The Johns Hopkins University, a Maryland corporation having an address at 3400 N. Charles St., Baltimore, MD 21218 (“JHU”) and OncoMethylome Sciences S.A. (formerly known as OncoGenome Sciences, S.A.), a corporation having an address at Niveau +2, Tour 4 de Pharmacie (batiment 36), Ulg CHU, Av. de l’Hopital no. 1, 4000 Sart-Tilman (Liege), Belgium (“Company”), with respect to the following:
Date: 19 April 2021Loan Facility Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • England and Wales
Contract Type FiledSeptember 23rd, 2021 Company Industry Jurisdiction
Dated 24 April 2020 Between MDxHealth SA and SUBSCRIPTION AGREEMENT relating to new ordinary shares of MDxHealth SASubscription Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories
Contract Type FiledSeptember 23rd, 2021 Company IndustryThe parties referred to sub (2) and (3) are hereinafter jointly referred to as the “Subscribers” and individually as a “Subscriber”;
AGREEMENTEmployment Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories
Contract Type FiledSeptember 23rd, 2021 Company IndustryOncoMethylome Sciences, Inc., a company incorporated in the state of Delaware and with offices in North Carolina. Hereinafter referred to as the COMPANY. The COMPANY is represented by Herman Spolders for purposes of this Agreement.
CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT IN ACCORDANCE WITH REGULATION S-K ITEM 601(B)(10)(IV). ASTERISKS DENOTE OMISSIONS. SUCH INFORMATION IS BOTH (i) IMMATERIAL AND (ii) IS OF A TYPE REGULARLY TREATED AS PRIVATE OR...Exclusive License Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • Maryland
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionThis Amended and Restated License Agreement (the “Agreement”) dated September 1, 2004 is entered into by and between The Johns Hopkins University, a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218-2695 (“JHU”) and OncoMethylome Sciences SA, a corporation having an address at Niveau +2, Tour 4 de Pharmacie (batiment 36), Ulg CHU, Av. de l’Hopital no. 1, 4000 Sart-Tilman (Liege), Belgium (“Company”), with respect to the following:
SECOND AMENDMENT TO LEASELease • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories
Contract Type FiledSeptember 23rd, 2021 Company Industry
FIRST AMENDMENT TO LEASELease • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories
Contract Type FiledSeptember 23rd, 2021 Company Industry
Date: 19 April 2021 KREOS CAPITAL V I (UK) LIMITED AND MDXHEALTH SA AMENDMENT AND RESTATEMENT AGREEMENT RELATING TO A CONVERTIBLE LOANS AGREEMENT ORIGINALLY DATED 23 SEPTEMBER 2019, AS AMENDED AND RESTATED ON 19 OCTOBER 2020Convertible Loans Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • England and Wales
Contract Type FiledSeptember 23rd, 2021 Company Industry Jurisdiction